200 related articles for article (PubMed ID: 16021084)
1. Calprotectin, a marker of inflammation, is elevated in the maternal but not in the fetal circulation in preeclampsia.
Braekke K; Holthe MR; Harsem NK; Fagerhol MK; Staff AC
Am J Obstet Gynecol; 2005 Jul; 193(1):227-33. PubMed ID: 16021084
[TBL] [Abstract][Full Text] [Related]
2. Calprotectin plasma level is elevated in preeclampsia.
Holthe MR; Staff AC; Berge LN; Fagerhol MK; Lyberg T
Acta Obstet Gynecol Scand; 2005 Feb; 84(2):151-4. PubMed ID: 15683375
[TBL] [Abstract][Full Text] [Related]
3. Relationship between maternal and cord blood hemostatic disturbances in preeclamptic pregnancies.
Catarino C; Rebelo I; Belo L; Rocha S; Castro EB; Patricio B; Quintanilha A; Santos-Silva A
Thromb Res; 2008; 123(2):219-24. PubMed ID: 18384840
[TBL] [Abstract][Full Text] [Related]
4. Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction.
Cetin I; Cozzi V; Pasqualini F; Nebuloni M; Garlanda C; Vago L; Pardi G; Mantovani A
Am J Obstet Gynecol; 2006 May; 194(5):1347-53. PubMed ID: 16647920
[TBL] [Abstract][Full Text] [Related]
5. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.
Park CW; Park JS; Shim SS; Jun JK; Yoon BH; Romero R
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):984-9. PubMed ID: 16157098
[TBL] [Abstract][Full Text] [Related]
6. Amniotic fluid and cord plasma erythropoietin levels in pregnancies complicated by preeclampsia, pregnancy-induced hypertension and chronic hypertension.
Teramo KA; Hiilesmaa VK; Schwartz R; Clemons GK; Widness JA
J Perinat Med; 2004; 32(3):240-7. PubMed ID: 15188798
[TBL] [Abstract][Full Text] [Related]
7. Involvement of fibrinolytic factors in mid trimester amniotic fluid with development of severe early-onset preeclampsia.
Adachi T; Nakabayashi M; Sakura M; Ando K
Semin Thromb Hemost; 1999; 25(5):447-50. PubMed ID: 10625200
[TBL] [Abstract][Full Text] [Related]
8. [C-reactive protein in women with pre-eclampsia].
Batashki I; Milchev N; Topalovska D; Uchikova E; Mateva N
Akush Ginekol (Sofiia); 2006; 45 Suppl 1():47-50. PubMed ID: 16673658
[TBL] [Abstract][Full Text] [Related]
9. Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia.
Levine RJ; Qian C; Leshane ES; Yu KF; England LJ; Schisterman EF; Wataganara T; Romero R; Bianchi DW
Am J Obstet Gynecol; 2004 Mar; 190(3):707-13. PubMed ID: 15042003
[TBL] [Abstract][Full Text] [Related]
10. Augmented oxidative stress as well as antioxidant capacity in maternal circulation in preeclampsia.
Harsem NK; Braekke K; Staff AC
Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):209-15. PubMed ID: 16337725
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between the expression of human leukocyte antigen G and preeclampsia].
Zhao SC; Li ZB; He TQ; Yu CZ
Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):758-62. PubMed ID: 22321350
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of the maternal and umbilical interleukin-8 levels in normal pregnancies and in pregnancies complicated by preeclampsia with intrauterine normal growth and intrauterine growth retardation.
Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
J Matern Fetal Neonatal Med; 2007 Jul; 20(7):527-32. PubMed ID: 17674266
[TBL] [Abstract][Full Text] [Related]
13. Activation of the complement system in normal pregnancy and preeclampsia.
Derzsy Z; Prohászka Z; Rigó J; Füst G; Molvarec A
Mol Immunol; 2010 Apr; 47(7-8):1500-6. PubMed ID: 20181396
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein production in term human placental tissue.
Malek A; Bersinger NA; Di Santo S; Mueller MD; Sager R; Schneider H; Ghezzi F; Karousou E; Passi A; De Luca G; Raio L
Placenta; 2006; 27(6-7):619-25. PubMed ID: 16026834
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein, marker for evaluation of systemic inflammatory response in preeclampsia.
Mihu D; Costin N; Mihu CM; Blaga LD; Pop RB
Rev Med Chir Soc Med Nat Iasi; 2008; 112(4):1019-25. PubMed ID: 20209780
[TBL] [Abstract][Full Text] [Related]
16. Preeclampsia is associated with decreased serum alpha(2)-HS glycoprotein (fetuin-A) concentration.
Molvarec A; Kalabay L; Derzsy Z; Szarka A; Halmos A; Stenczer B; Arnaud P; Karádi I; Prohászka Z; Rigó J
Hypertens Res; 2009 Aug; 32(8):665-9. PubMed ID: 19478814
[TBL] [Abstract][Full Text] [Related]
17. Neurokinin B levels in maternal and umbilical cord blood in preeclamptic and normal pregnancies.
Zulfikaroglu E; Ugur M; Taflan S; Ugurlu N; Atalay A; Kalyoncu S
J Perinat Med; 2007; 35(3):200-2. PubMed ID: 17480147
[TBL] [Abstract][Full Text] [Related]
18. Reduced third-trimester levels of soluble human leukocyte antigen G protein in severe preeclampsia.
Hackmon R; Koifman A; Hyodo H; Glickman H; Sheiner E; Geraghty DE
Am J Obstet Gynecol; 2007 Sep; 197(3):255.e1-5. PubMed ID: 17826409
[TBL] [Abstract][Full Text] [Related]
19. Circulating calcitonin gene-related peptide and its placental origins in normotensive and preeclamptic pregnancies.
Dong YL; Chauhan M; Green KE; Vegiraju S; Wang HQ; Hankins GD; Yallampalli C
Am J Obstet Gynecol; 2006 Dec; 195(6):1657-67. PubMed ID: 16996466
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of maternal and umbilical serum TNFalpha levels in preeclamptic pregnancies in the intrauterine normal and growth-restricted fetus.
Laskowska M; Leszczyńska-Gorzelak B; Laskowska K; Oleszczuk J
J Matern Fetal Neonatal Med; 2006 Jun; 19(6):347-51. PubMed ID: 16801311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
